Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy

ConclusionSwitching to heDMT is associated with reduced ARR and delay of first relapse compared with switching to meDMT. Patients on DMT who experience relapses should escalate therapy to heDMT.
Source: Journal of Neurology - Category: Neurology Source Type: research